Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,226 | 12,454 | 26,371 | 11,264 | 8,829 |
| Marketable Securities | 152,691 | 172,445 | 175,732 | 204,871 | 219,429 |
| TOTAL | $179,863 | $193,299 | $210,528 | $224,285 | $237,662 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,645 | 1,729 | 134 | 189 | 183 |
| TOTAL | $1,645 | $1,729 | $134 | $189 | $183 |
| Total Assets | $181,508 | $195,028 | $210,662 | $224,474 | $237,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,104 | 3,119 | 1,444 | 2,852 | 4,210 |
| TOTAL | $14,864 | $11,268 | $8,778 | $11,353 | $12,871 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,414 | 1,490 | 0 | 0 | 0 |
| TOTAL | $1,414 | $1,490 | $N/A | $N/A | $N/A |
| Total Liabilities | $16,278 | $12,758 | $8,778 | $11,353 | $12,871 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,688 | 77,374 | 78,363 | 78,235 | 78,190 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -256,717 | -239,285 | -223,182 | -210,826 | -197,583 |
| Other shareholders' equity | -1,444 | -1,532 | -549 | -170 | -189 |
| TOTAL | $165,230 | $182,270 | $201,884 | $213,121 | $224,974 |
| Total Liabilities And Equity | $181,508 | $195,028 | $210,662 | $224,474 | $237,845 |